Kathy Dong is the President and CEO of Electra Therapeutics, where they have served in various leadership roles since 2019. Previously, Kathy was the Chief Operating Officer at both Vega Therapeutics and Star Therapeutics, and Vice President of Commercial Development at True North Therapeutics. With a strong foundation in marketing, Kathy led significant product launches at Gilead Sciences, including HARVONI and EPCLUSA, during their tenure as Director of HCV Marketing. Kathy holds a Doctor of Pharmacy and a Masters of Business Administration from The University of New Mexico and is currently a board member at Neuron23.
This person is not in the org chart
This person is not in any teams
This person is not in any offices